Document is current
Any future updates will be listed below
-
Authors
Yanagisawa, Takafumi https://orcid.org/0000-0002-7410-0712
Matsukawa, Akihiro
Iwatani, Kosuke
Sato, Shun
Hayashida, Yasushi
Okada, Yohei
Yorozu, Takashi
Fukuokaya, Wataru
Sakanaka, Keigo
Urabe, Fumihiko
Kimura, Shoji
Tsuzuki, Shunsuke
Shimoda, Masayuki
Takahashi, Hiroyuki
Miki, Jun
Shariat, Shahrokh F.
Kimura, Takahiro
- License Information
-
More Information
Article History
Received: 4 October 2022
Accepted: 23 January 2023
First Online: 10 March 2023
Disclosure
: Takahiro Kimura is a paid consultant/advisor of Astellas, Bayer, Janssen, and Sanofi. Shahrokh F. Shariat received as follows: honoraria include Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Roche, and Takeda; consulting or advisory roles include Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Pierre Fabre, Roche, and Takeda; and speakers bureau includes Astellas, Astra Zeneca, Bayer, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Richard Wolf, Roche, and Takeda. The other authors declare no conflicts of interest associated with this manuscript.
